Gold prices steady, holding sharp gains in wake of soft U.S. jobs data
Investing.com - CVS Health Corp (NYSE: CVS) reported second quarter EPS of $1.81, $0.35 better than the analyst estimate of $1.46. Revenue for the quarter came in at $98.9B versus the consensus estimate of $94.73B.
Guidance
CVS Health Corp sees FY 2025 EPS of $6.30-$6.40 versus the analyst consensus of $6.12.
CVS Health Corp’s stock price closed at $62.30. It is down -7.65% in the last 3 months and up 3.78% in the last 12 months.
CVS Health Corp saw 3 positive EPS revisions and 19 negative EPS revisions in the last 90 days. See CVS Health Corp’s stock price’s past reactions to earnings here.
According to InvestingPro, CVS Health Corp’s Financial Health score is "good performance".
Check out CVS Health Corp’s recent earnings performance, and CVS Health Corp’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar